HUP0003127A2 - Helyetesített heterogyűrűs vegyületek, eljárás előállításukra, valamint ezeket tartalmazó gyógyászati készítmények - Google Patents
Helyetesített heterogyűrűs vegyületek, eljárás előállításukra, valamint ezeket tartalmazó gyógyászati készítményekInfo
- Publication number
- HUP0003127A2 HUP0003127A2 HU0003127A HUP0003127A HUP0003127A2 HU P0003127 A2 HUP0003127 A2 HU P0003127A2 HU 0003127 A HU0003127 A HU 0003127A HU P0003127 A HUP0003127 A HU P0003127A HU P0003127 A2 HUP0003127 A2 HU P0003127A2
- Authority
- HU
- Hungary
- Prior art keywords
- group
- carbon atoms
- hydrogen atom
- oxygen
- general formula
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title 1
- 150000001420 substituted heterocyclic compounds Chemical class 0.000 title 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 4
- 125000003118 aryl group Chemical group 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 3
- 125000004430 oxygen atom Chemical group O* 0.000 abstract 3
- 229910052760 oxygen Inorganic materials 0.000 abstract 2
- 239000001301 oxygen Substances 0.000 abstract 2
- 238000002360 preparation method Methods 0.000 abstract 2
- 229910052717 sulfur Chemical group 0.000 abstract 2
- 125000004434 sulfur atom Chemical group 0.000 abstract 2
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000000304 alkynyl group Chemical group 0.000 abstract 1
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 1
- 125000004429 atom Chemical group 0.000 abstract 1
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 230000001193 melatoninergic effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- 125000000547 substituted alkyl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- C07D311/60—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/78—Ring systems having three or more relevant rings
- C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
- C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
- C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D319/20—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
- C07D339/08—Six-membered rings
Abstract
A találmány tárgyát az (I) általános képletű vegyületek és ezekenantiomerjei, diasztereoizomerjei, valamint gyógyászati szempontbólelfogadható savval vagy bázissal alkotott addíciós sói képezik - aképletben R1 jelentése hidrogénatom, adott esetben helyettesítettalkil-, alkenil-, alkinil-, cikloalkil- vagy cikloalkil-alkilcsoport,vagy -OR4 általános képletű csoport, R2 jelentése hidrogénatom, vagyR1 és R2 két szomszédos szénatomon helyezkedik el, és a közrezártszénatomokkal együtt arilcsoportot vagy 1 vagy 2 oxigénatomottartalmazó hattagú gyűrűt alkot; X jelentése oxigén- vagy kénatom, -C(H)q-csoport, ahol q értéke 0, 1 vagy 2, -SO- vagy -SO2-, vagy Yjelentése oxigén- vagy kénatom, -C(H)q-csoport, ahol q értéke 0, 1vagy 2, -SO- vagy -SO2-; azzal a megkötéssel, hogy X és Y nem lehetegyidejűleg -C(H)q-csoport, ahol q értéke 0, 1 vagy 2, R3 jelentésehidrogénatom, aril- vagy aril-alkilcsoport, n értéke 0, 1, 2, 3, 4vagy 5, ha a két szomszédos szénatomon elhelyezkedő R1 és R2helyettesítő a közrezárt szénatomokkal együtt arilcsoportot vagyhattagú, 1 vagy 2 oxigénatomot tartalmazó gyűrűt alkot, vagy n értéke1, 2, 3, 4 vagy 5, ha R' jelentése az előzőekben megadott és R2jelentése hidrogénatom, és a -(CH2)n-lánc adott esetben egyszeresenvagy többszörösen helyettesített; A jelentése -NR5R6 vagy -C(Z)-NR8R9általános képletű csoport, a pontozott vegyértékkötés szimbólumjelentése, hogy a kötések egyszeresek vagy kétszeresek, azzal amegkötéssel, hogy két szomszédos kötés nem lehet egyidejűleg kétszeresés hogy az atomok vegyértékeit tekintetbe kell venni. A találmánytárgyát képezi továbbá a fenti vegyületek előállítására szolgálóeljárás, valamint a fenti vegyületeket hatóanyagként tartalmazógyógyászati készítmények, különösen a melatoninerg rendszerrendellenességeinek kezelésére szolgáló gyógyászati készítmények. Ó
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9706019A FR2763335B1 (fr) | 1997-05-16 | 1997-05-16 | Nouveaux composes heterocycliques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP0003127A2 true HUP0003127A2 (hu) | 2002-05-29 |
HUP0003127A3 HUP0003127A3 (en) | 2002-12-28 |
Family
ID=9506957
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0003127A HUP0003127A3 (en) | 1997-05-16 | 1998-05-14 | Substituted heterocyclic compounds, method for preparing and compositions containing same |
Country Status (21)
Country | Link |
---|---|
US (2) | US6313160B1 (hu) |
EP (1) | EP0998471B1 (hu) |
JP (1) | JP2002510290A (hu) |
CN (1) | CN1139584C (hu) |
AT (1) | ATE356814T1 (hu) |
AU (1) | AU741753B2 (hu) |
BR (1) | BR9809643A (hu) |
CA (1) | CA2289599C (hu) |
CY (1) | CY1106545T1 (hu) |
DE (1) | DE69837334T2 (hu) |
DK (1) | DK0998471T3 (hu) |
ES (1) | ES2285775T3 (hu) |
FR (1) | FR2763335B1 (hu) |
HK (1) | HK1028028A1 (hu) |
HU (1) | HUP0003127A3 (hu) |
NO (1) | NO324562B1 (hu) |
NZ (1) | NZ500952A (hu) |
PL (1) | PL197156B1 (hu) |
PT (1) | PT998471E (hu) |
WO (1) | WO1998052935A1 (hu) |
ZA (1) | ZA984114B (hu) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2799757B1 (fr) * | 1999-10-15 | 2001-12-14 | Adir | Nouveaux derives polycycliques azaindoliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
US6552069B1 (en) * | 1999-12-13 | 2003-04-22 | Chugai Seiyaku Kabushiki Kaisha | 3-methyl-chroman and -thiochroman derivatives |
DE10344412A1 (de) * | 2003-09-25 | 2005-05-19 | Röhm GmbH & Co. KG | Polymernetzwerke |
CA2605587A1 (en) * | 2005-04-22 | 2006-11-02 | Wyeth | Chromane and chromene derivatives and uses thereof |
CN1891687B (zh) * | 2005-07-08 | 2011-08-03 | 中国医学科学院医药生物技术研究所 | 微生物来源的炎症因子受体拮抗活性化合物及其应用 |
ES2391326T3 (es) * | 2008-05-23 | 2012-11-23 | Novaera S.R.L. | Formulaciones de endipaleno en el tratamiento de la psoriasis |
CA3042107C (en) * | 2009-11-03 | 2023-03-07 | Fosun Orinove Pharmatech, Inc. | Ire-1.alpha. inhibitors |
KR102022154B1 (ko) * | 2016-11-24 | 2019-09-18 | 한양대학교 산학협력단 | MBD2-p66α(GATAD2A)의 상호작용을 억제하는 화합물을 포함하는 암 전이 억제 및 암 질환 예방 및 치료용 조성물 |
US10052326B1 (en) | 2017-10-12 | 2018-08-21 | King Saud University | Antihepatotoxic agents |
CN111960970B (zh) * | 2018-08-08 | 2021-08-20 | 中国人民解放军总医院 | 抗肿瘤化合物 |
Family Cites Families (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3663702A (en) * | 1967-05-05 | 1972-05-16 | Colgate Palmolive Co | Pharmaceutical compositions containing amides of beta-(3 - thianaphthenyl)ethylamines |
US3509170A (en) * | 1967-06-12 | 1970-04-28 | Du Pont | Heterocyclic amino-oxazolines |
BE806220A (fr) * | 1972-10-20 | 1974-02-15 | Luso Farmaco Inst | Nouveaux esters et amides d'acides 3-aryl-1,4-benzodioxanne- 2-ylcarboxyliques |
FR2424741A1 (fr) * | 1977-03-17 | 1979-11-30 | Shell Int Research | Compositions biologiquement actives contre la formation de lipides et de cholesterol chez les mammiferes |
BE868304A (nl) * | 1977-06-30 | 1978-12-21 | Shell Int Research | Werkwijze ter bereiding van een verbinding voor het tegengaan van lipogenese. |
US4205079A (en) * | 1978-10-16 | 1980-05-27 | Shell Oil Company | Benzodioxincarboxamides |
DE3367391D1 (en) * | 1982-12-23 | 1986-12-11 | Ici America Inc | Chroman compounds |
GB8515389D0 (en) * | 1985-06-18 | 1985-07-17 | Ici Plc | Heterocyclic compounds |
PT84806B (pt) * | 1986-05-03 | 1989-12-29 | Beecham Group Plc | Processo para a preparacao de benzopiranos |
FR2618437B1 (fr) * | 1987-07-23 | 1989-11-17 | Rhone Poulenc Sante | Nouveaux derives du benzopyranne, leur preparation et les medicaments qui les contiennent |
US4868210A (en) * | 1988-03-30 | 1989-09-19 | Warner-Lambert Company | Antihyperlipidemic and antiatherosclerotic compounds and compositions |
KR900701774A (ko) * | 1988-08-16 | 1990-12-04 | 제임스 제이. 플린 | 살진균성 벤조디옥산 아민 유도체 |
EP0389425B1 (de) * | 1989-03-22 | 1995-04-26 | Ciba-Geigy Ag | Neue Benzothiopyranylamine |
FR2658818B1 (fr) * | 1990-02-27 | 1993-12-31 | Adir Cie | Nouveaux derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
FR2661676A1 (fr) * | 1990-05-02 | 1991-11-08 | Lipha | Derives d'amino benzocycloalcanes, procedes de preparation et medicaments les contenant. |
EP0583346A1 (en) * | 1991-04-12 | 1994-02-23 | Schering Corporation | Bicyclic amides as inhibitors of acyl-coenzyme a: cholesterol acyl transferase |
FR2680366B1 (fr) * | 1991-08-13 | 1995-01-20 | Adir | Nouveaux derives d'arylethylamines, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent. |
FR2696453B1 (fr) * | 1992-10-02 | 1994-12-23 | Adir | Nouveaux arylalkyl(thio)amides, leur procédé de préparation, et les compositions pharmaceutiques qui les contiennent. |
PT690843E (pt) * | 1993-03-25 | 2001-01-31 | Upjohn Co | Derivados de indolo substituidos com formilo ou ciano possuindo actividade dopaminergica |
FR2704857B1 (fr) * | 1993-05-07 | 1995-06-23 | Adir | Nouvelles benzodioxines substituées, leur procédé de préparation et les compositions pharmaceutiques les contenant. |
GB9326192D0 (en) * | 1993-12-22 | 1994-02-23 | Glaxo Group Ltd | Chemical compounds |
FR2716680B1 (fr) * | 1994-02-25 | 1996-04-05 | Adir | Nouveaux dérivés de benzodioxane, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent. |
JPH07242543A (ja) * | 1994-03-03 | 1995-09-19 | Taiho Yakuhin Kogyo Kk | 肝疾患治療剤 |
JPH07242655A (ja) * | 1994-03-03 | 1995-09-19 | Taiho Yakuhin Kogyo Kk | 1,4−ベンゾジオキサン誘導体 |
GB9407919D0 (en) * | 1994-04-21 | 1994-06-15 | Glaxo Group Ltd | Chemical compounds |
FR2725985B1 (fr) * | 1994-10-21 | 1996-11-15 | Adir | Nouveaux composes tricycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
FR2729147A1 (fr) * | 1995-01-11 | 1996-07-12 | Adir | Nouveaux composes (hetero) cycliques alkyles, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
FR2732969B1 (fr) * | 1995-04-14 | 1997-05-16 | Adir | Nouveaux composes pyridiniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
FR2734814B1 (fr) * | 1995-05-31 | 1997-07-04 | Adir | Nouveaux composes alkoxy-aryles, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
FR2734815B1 (fr) * | 1995-05-31 | 1997-07-04 | Adir | Nouveaux composes arylalkyl (thio) carboxamides, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent |
FR2734816B1 (fr) * | 1995-05-31 | 1997-07-04 | Adir | Nouveaux aryl (alkyl) propylamides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
-
1997
- 1997-05-16 FR FR9706019A patent/FR2763335B1/fr not_active Expired - Fee Related
-
1998
- 1998-05-14 JP JP55002898A patent/JP2002510290A/ja not_active Ceased
- 1998-05-14 AT AT98925703T patent/ATE356814T1/de not_active IP Right Cessation
- 1998-05-14 US US09/423,745 patent/US6313160B1/en not_active Expired - Fee Related
- 1998-05-14 EP EP98925703A patent/EP0998471B1/fr not_active Expired - Lifetime
- 1998-05-14 CA CA002289599A patent/CA2289599C/fr not_active Expired - Fee Related
- 1998-05-14 WO PCT/FR1998/000954 patent/WO1998052935A1/fr active IP Right Grant
- 1998-05-14 HU HU0003127A patent/HUP0003127A3/hu unknown
- 1998-05-14 ES ES98925703T patent/ES2285775T3/es not_active Expired - Lifetime
- 1998-05-14 AU AU77723/98A patent/AU741753B2/en not_active Ceased
- 1998-05-14 CN CNB988062844A patent/CN1139584C/zh not_active Expired - Fee Related
- 1998-05-14 BR BR9809643-5A patent/BR9809643A/pt not_active Application Discontinuation
- 1998-05-14 NZ NZ500952A patent/NZ500952A/en unknown
- 1998-05-14 PL PL336857A patent/PL197156B1/pl unknown
- 1998-05-14 DE DE69837334T patent/DE69837334T2/de not_active Expired - Fee Related
- 1998-05-14 DK DK98925703T patent/DK0998471T3/da active
- 1998-05-14 PT PT98925703T patent/PT998471E/pt unknown
- 1998-05-15 ZA ZA984114A patent/ZA984114B/xx unknown
-
1999
- 1999-11-15 NO NO19995594A patent/NO324562B1/no unknown
-
2000
- 2000-11-17 HK HK00107327A patent/HK1028028A1/xx not_active IP Right Cessation
-
2001
- 2001-08-28 US US09/941,016 patent/US6602903B2/en not_active Expired - Fee Related
-
2007
- 2007-04-26 CY CY20071100565T patent/CY1106545T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
AU7772398A (en) | 1998-12-11 |
ES2285775T3 (es) | 2007-11-16 |
NO995594D0 (no) | 1999-11-15 |
PT998471E (pt) | 2007-06-05 |
CN1139584C (zh) | 2004-02-25 |
CA2289599A1 (fr) | 1998-11-26 |
PL197156B1 (pl) | 2008-03-31 |
CN1260789A (zh) | 2000-07-19 |
NO324562B1 (no) | 2007-11-19 |
CY1106545T1 (el) | 2012-01-25 |
EP0998471B1 (fr) | 2007-03-14 |
FR2763335B1 (fr) | 2000-11-24 |
JP2002510290A (ja) | 2002-04-02 |
HK1028028A1 (en) | 2001-02-02 |
US6602903B2 (en) | 2003-08-05 |
US6313160B1 (en) | 2001-11-06 |
WO1998052935A1 (fr) | 1998-11-26 |
FR2763335A1 (fr) | 1998-11-20 |
AU741753B2 (en) | 2001-12-06 |
DK0998471T3 (da) | 2007-07-02 |
DE69837334D1 (de) | 2007-04-26 |
EP0998471A1 (fr) | 2000-05-10 |
NO995594L (no) | 2000-01-14 |
US20020052400A1 (en) | 2002-05-02 |
ATE356814T1 (de) | 2007-04-15 |
CA2289599C (fr) | 2005-12-06 |
PL336857A1 (en) | 2000-07-17 |
NZ500952A (en) | 2002-03-01 |
HUP0003127A3 (en) | 2002-12-28 |
BR9809643A (pt) | 2000-10-03 |
ZA984114B (en) | 1998-11-24 |
DE69837334T2 (de) | 2008-01-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE188216T1 (de) | Therapeutische mittel für die parkinsonsche krankheit | |
YU45403A (sh) | Novi 1,2-difenil-azetidinoni, postupak za njihovu proizvodnju, lekovi koji sadrže ova jedinjenja i njihova primena za lečenje poremećaja u metabolizmu lipida | |
MD420C2 (ro) | Derivaţi ai acidului acrilic | |
MY104627A (en) | A 1-pyridylimidazole derivative and its production and use. | |
HUP0103111A2 (hu) | Epotilonszármazékok, eljárás az előllításukra és alkalmazásuk | |
BG105177A (en) | Novel substituted pyrazole derivatives | |
HUP9600448A2 (hu) | Naftilvegyületek, e vegyületeket tartalmazó gyógyszerkészítmények, eljárás előállításukra, intermedierjeik és alkalmazásuk | |
DE199636T1 (de) | Benzoenaphthalinderivate, verfahren zu deren herstellung und ihre verwendung in pharmazie und kosmetik. | |
HUP9901079A2 (hu) | 5- és 6-Tagú nitrogéntartalmú gyűrűs vegyületek, eljárás előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
MY100073A (en) | Pyrazolecarboxamide derivative, a method for preparing the same and fungicide containing it as active ingredient. | |
HUP0102187A2 (hu) | Azolo-triazinok és -pirimidinek, ezeket tartalmazó gyógyászati készítmények, valamint e vegyületek alkalmazása | |
DE68914292T2 (de) | Zusammensetzung zur Behandlung von ischämischen Störungen in Organen. | |
NO952129L (no) | Oksalylamino-benzofuran- og benzotienyl-derivater | |
UA48937C2 (uk) | Імідазолідини, заміщені гетероциклом, спосіб їх одержання і фармацевтична композиція, що їх містить | |
HUP9802937A2 (hu) | Benzo[g]kinolin-származékok, e vegyületeket tartalmazó gyógyászati készítmények, eljárás előállításukra és alkalmazásuk | |
HK1008529A1 (en) | Pentacyclic compounds | |
TW368501B (en) | 7-(2-aminoethyl)-benzothiazolones | |
HUP0003127A2 (hu) | Helyetesített heterogyűrűs vegyületek, eljárás előállításukra, valamint ezeket tartalmazó gyógyászati készítmények | |
HUP9900851A2 (hu) | Benzotiofénszármazékok felhasználása véredény simaizom sejtek migrálásának inhibiálására alkalmas gyógyszerkészítmények előállítására | |
HUP0402385A2 (hu) | 5-Fenil-pirimidinek, ezeket tartalmazó fungicid készítmények, eljárás előállításukra és alkalmazásuk | |
ATE57919T1 (de) | Triazinderivate, verfahren zur herstellung der derivate und die derivate als wirksamen bestandteil enthaltende herbizide. | |
YU57601A (sh) | Epotilon derivati, postupak za njihovu izradu i njihova farmaceutska primena | |
HUP0401018A2 (hu) | 2H-1-benzopirán-származékok, eljárás ezek előállítására és ezeket tartalmazó gyógyászati készítmények | |
ES455741A1 (es) | Un procedimiento para la preparacion de nuevos derivados de 1,3-bencenodimetanol. | |
PL335012A1 (en) | Novel derivatives of indan-1-ole, method of obtaining and composition containing them |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA9A | Lapse of provisional patent protection due to relinquishment or protection considered relinquished |